STAT+: FDA alters warning label for Carvykti CAR-T, although link to secondary cancers is unclear
STAT
DECEMBER 22, 2023
“I do not believe this particular change will have any bearing on patient care,” said Saad Usmani, a myeloma physician and cell therapist at Memorial Sloan Kettering who has also studied Carvykti.
Let's personalize your content